Rationale for extended adjuvant letrozole after five years of tamoxifen in postmenopausal oestrogen receptor-positive women with early-stage breast cancer

Heather L. McArthur, H. F. Kennecke

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)78-82
Number of pages5
JournalCurrent Oncology
Issue number3
StatePublished - Sep 2005
Externally publishedYes

ASJC Scopus subject areas

  • Oncology

Cite this